Hans-Peter Gerber
Chief Scientific Officer, Sutro Biopharma.
Companies
- Sutro BiopharmaChief Scientific Officer Sep 19, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Sutro Biopharma STRO12,367 shares2$139.5K at $11.28Sep 18, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 18, 2026Shares withheld for tax 1,345 shares at $15.34 of Sutro Biopharma2
- Sep 18, 2026Exercised options 3,750 shares of Sutro Biopharma2
- Mar 2, 2026Shares withheld for tax 1,170 shares at $20.55 of Sutro Biopharma3
- Mar 2, 2026Exercised options 2,843 shares of Sutro Biopharma3
- Mar 1, 2026Shares withheld for tax 463 shares at $20.47 of Sutro Biopharma3
- Mar 1, 2026Exercised options 1,125 shares of Sutro Biopharma3
- Oct 15, 2025Bought 17,000 shares at $0.80 of Sutro Biopharma4
- Sep 18, 2025Shares withheld for tax 13,417 shares at $0.90 of Sutro Biopharma5
- Sep 18, 2025Exercised options 37,500 shares of Sutro Biopharma5
- Mar 1, 2025Shares withheld for tax 4,621 shares at $1.59 of Sutro Biopharma6
- Mar 1, 2025Exercised options 11,250 shares of Sutro Biopharma6
- Sep 18, 2024Shares withheld for tax 13,380 shares at $3.95 of Sutro Biopharma7
- Sep 18, 2024Exercised options 37,500 shares of Sutro Biopharma7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 3, 2026
- 4SEC EDGARForm 4 filed Oct 16, 2025
- 5SEC EDGARForm 4 filed Sep 22, 2025
- 6SEC EDGARForm 4 filed Mar 4, 2025
- 7SEC EDGARForm 4 filed Sep 20, 2024